MESALAZINE PREFORMULATION AND SOLUBILITY STUDY
DOI:
https://doi.org/10.22159/ijap.2026v18i1.55689Keywords:
Preformulation, Meslazine, Ulcerative colitis, Drug-excipients compatibility studiesAbstract
Objective: Aim of preformulation study is to develop the elegant, stable, effective and safe dosage form by assay solubility and stability study of MSL.
Methods: Preformulation study was done to check the purity and stability of drug by different steps of preformulation study, first of this step involve identification of melting point by DSC, and by using UV spectrophotometry can be detection of lambda max and calibration curve in ethanol and phosphate buffer pH7.4. Drug was dissolved in different media to evaluate its solubility and stability in The study includes solubility, stability, and pH of drug in different oil (Almond oil, Grape oil, Sesame oil, Clove oil, Olive oil, Jojoba oil, and Labrafil oil), different surfactants (Cremophor, Tween 40, Tween 80, PEG 400, PEG600, PEG200, Labrasol), different co surfactants (Oleic acid, Imm 948, Vitamin E, frankincense oil, Labrafac oil, and Imwitor30 with and without different antioxidants (sodium thiosulfate, sodium metabisulfite, vitamin C, and Vitamin E. FTIR done to check purity and identity of drug and to evaluate MSL-solubilizing media interaction.
Results: The results from the Preformulation studies show melting point and lambda max of mesalamine were found to be 285.5 °C and 330 nm respectively. MSL best condition of preparing in a solution in oil and acidic media at room temperature. The FTIR study of pure MSL confirms the purity of drug and FTIR show the interaction of drug with tween 40; in which FTIR of MSL-tween40 show chemical interaction.
Conclusion: from solubility study of MSL in deferent media show different concentration of drug dissolve in mg/ml and stability of drug was affected by type of media mainly pH of media in which oil media show better stability.
References
1. Ahmed Elbashir A. Development and validation of spectrophotometric methods for the determination of mesalazine in pharmaceutical formulation. Med chem. 2014;4(3):361-6. doi: 10.4172/2161-0444.1000166.
2. Wani M, Rodge P, Baheti A, Polshettiwar S, Nandgude T, Tamboli F. Preformulation studies of glipizide: first step towards developing stable osmotic drug delivery system. Res J Pharm Technol. 2022;15(1):29-34. doi: 10.52711/0974-360X.2022.00006.
3. Jaitly A, Sharma R, Zafar R. Formulation and evaluation of cefuroxime axetil granules for oral suspension. Asian J Pharm Clin Res. 2023;16(7):180-6. doi: 10.22159/ajpcr.2023.v16i7.47397.
4. Chaurasia G. A review on pharmaceutical preformulation studies in formulation and development of new drug molecules. Int J Pharm Sci Res. 2016;7(6):2313–20. doi: 10.13040/IJPSR.0975-8232.7(6).2313-20.
5. Yadav AV, Yadav VB. Improvement of physicochemical properties of mesalamine with hydrophilic carriers by solid dispersion (kneading) method. Res J Pharm Technol. 2008;1(4):422-5.
6. Wadworth AN, Fitton A, Olsalazine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in inflammatory bowel disease. Drugs. 1991;41(4):647-64. doi: 10.2165/00003495-199141040-00009, PMID 1711964.
7. Mazaher Haji Agha E, Barzegar Jalali M, Adibkia K, Hemmati S, Martinez F, Jouyban A. Solubility and thermodynamic properties of mesalazine in {2-propanol + water} mixtures at various temperatures. J Mol Liq. 2020;301:112474. doi: 10.1016/j.molliq.2020.112474.
8. Ye B, Van Langenberg DR. Mesalazine preparations for the treatment of ulcerative colitis: are all created equal? World J Gastrointest Pharmacol Ther. 2015;6(4):137-44. doi: 10.4292/wjgpt.v6.i4.137, PMID 26558148.
9. Al Obaidi MSM. Spectrophotometric determination of mesalazine by formation of ion pair complex. Eurasian Chem Commun. 2022 Feb;4(9):826-34. doi: 10.22034/ecc.2022.329317.1350.
10. Guler E, Poturcu K, Rahimpour E, Jouyban A. Determination of the mesalazine solubility at biorelevant temperature. IJAMSC. 2024;12(1):1-12. doi: 10.4236/ijamsc.2024.121001.
11. Thamer AK, Abood AN. Preparation and in vitro characterization of aceclofenac nanosuspension (ACNS) for enhancement of percutaneous absorption using hydrogel dosage form. Iraqi J Pharm Sci. 2021;30(2):86-98. doi: 10.31351/vol30iss2pp86-98.
12. Jassim ZE, Al Kinani KK, Alwan ZS. Preparation and evaluation of pharmaceutical cocrystals for solubility enhancement of dextromethorphan HBr. International Journal of Drug Delivery Technology. 2021; 11(4):1342–9. doi: 10.25258/ijddt.11.4.37.
13. Gupta K, Roy SB, Singhvi I. Preformulation study in the development of a tablet formulation for the treatment of ulcerative colitis. Int J Pharm Drug Anal. 2015;3(6):214-22.
14. Newton AM, Prabakaran L, Jayaveera KN. Formulation development, optimization and study on drug release kinetics of eudragit ® L100-HPMC E15 LV mixed film-coated colon-targeted Mesalamine tablets. Asian J Pharm. 2012;6(3):180-9. doi: 10.4103/0973-8398.104832.
15. Ghurghure S, Sawant K, Deokar SS. UV spectrophotometric method development and validation of mesalazine in bulk and solid dosage form (research article). Int J Pharm Biol Sci. 2021;11(1):131-5. doi: 10.21276/ijpbs.2021.11.1.17.
16. Kaur G, Chauhan V, Kumar K, Teotia D. Development and evaluation of mesalamine gastro-resistant tablets. J Adv Sci Res. 2019;10(4):106-16.
17. Aziz AT, Sultan SH. Spectrophotometric determination of mesalazine in pharmaceutical preparations by oxidative coupling reactions with m-aminophenol and 2,6-dihydroxybenzoic acid. Baghdad Sci J. 2019;16(4):1010-6. doi: 10.21123/bsj.2019.16.4(Suppl.).1010.
18. Salih E, Mohammed AE. Spectrophotometric assay of mesalazine in pharmaceutical preparations via oxidative coupling reaction with o-cresol and sodium metaperiodate. J Educ Sci. 2020;29(1):279-92. doi: 10.33899/edusj.2020.172815.
19. El Zein R, Ispas Szabo P, Jafari M, Siaj M, Mateescu MA. Oxidation of mesalamine under phenoloxidase- or peroxidase-like enzyme catalysis. Molecules. 2023;28(24):8105. doi: 10.3390/molecules28248105, PMID 38138595.
20. Dung NT, Dao DT, Hoat GD, Son NA. Development of spectrophotometric method for determination of ceftazidime with the Bratton–Marshall reagent in pharmaceutical preparation. JST. 2017;55(2):220. doi: 10.15625/0866-708X/55/2/8676.
21. Freeland JC. The determination of acidity in mineral oils. Johannesburg: Electricity Supply Commission; 1942. p. 49–52.
22. Gupta BS, Vallabhaneni MR. Electrochemical recognition and electrochemical oxidation of mesalazine drug at PMA modified glassy carbon electrode. Int J Pharm Investig. 2021;11(4):389-94. doi: 10.5530/ijpi.2021.4.70.
23. Jukic Spika M, Kraljic K, Skevin D. Tocopherols: chemical structure, bioactivity and variability in Croatian virgin olive oils. In: Boskou D, Clodoveo ML, editors. Products from Olive Tree. London (UK): InTech; 2016. p. 317–29. doi: 10.5772/64658.
24. Park NH, Manica M, Born J, Hedrick JL, Erdmann T, Zubarev DY. Artificial intelligence-driven design of catalysts and materials for ring-opening polymerization using a domain-specific language. Nat Commun. 2023;14(1):3686. doi: 10.1038/s41467-023-39396-3, PMID 37344485.
25. Kumar AA, Rani TS, Ganesh PS, Swamy BE. Electrochemical oxidation of masala zine drug at poly(glutamic acid) modified glassy carbon electrode. Anal Bioanal Electrochem. 2017;9(3):328-39.
26. Tan TC, Cheng LH, Bhat R, Rusul G, Easa AM. Effectiveness of ascorbic acid and sodium metabisulfite as anti-browning agent and antioxidant on green coconut water (Cocos nucifera) subjected to elevated thermal processing. Int Food Res J. 2015;22(2):631-7.
27. Lavoie JC, Lachance C, Chessex P. Antiperoxide activity of sodium metabisulfite a double-edged sword. Biochem Pharmacol. 1994;47(5):871-6. doi: 10.1016/0006-2952(94)90487-1, PMID 8135862.
28. Sharma M, Joshi B, Bansal M, Goswami M. Formulation and evaluation of colon-targeted tablets of mesalazine. J Drug Delivery Ther. 2012;2(5):24-36. doi: 10.22270/jddt.v2i5.290.
29. Alhadad KS, AL Salman HN. Chromatographic spectrophotometric determination using reverse-phase HPLC technique for mesalazine or mesalamine. Georgian Med News. 2023;342(342):58-65. PMID 37991958.
30. Alam MM, Tasneem F, Kabir AL, Rouf AS. Study of drug-drug and drug-food interactions of mesalazine through FTIR and DSC. Dhaka Univ J Pharm Sci. 2019;18(2):257-69. doi: 10.3329/dujps.v18i2.44466.
31. Simoes A, Ramos A, Domingues F, Luis A. Pullulan-tween 40 emulsified films containing geraniol: production and characterization as potential food packaging materials. Eur Food Res Technol. 2024;250(6):1721-32. doi: 10.1007/s00217-024-04514-y.
Published
How to Cite
Issue
Section
Copyright (c) 2026 RUSSUL HAMEED, MOWAFAQ M. GHAREEB
This work is licensed under a Creative Commons Attribution 4.0 International License.